Go Pro
OTCMKTS:CLPBF

Coloplast A/S (CLPBF) Stock Price, News & Analysis

Coloplast A/S logo
$65.02 0.00 (0.00%)
As of 08/14/2026

About Coloplast A/S Stock (OTCMKTS:CLPBF)

Advanced

Key Stats

Today's Range
$65.02
$65.02
50-Day Range
$56.81
$67.36
52-Week Range
$56.81
$98.58
Volume
N/A
Average Volume
1,700 shs
Market Capitalization
N/A
P/E Ratio
5.69
Dividend Yield
11.53%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Coloplast A/S is a Denmark‐based medical device company specializing in the development and manufacturing of products and services for people with intimate healthcare needs. Founded in 1957 by Aage Louis‐Hansen and Poul Mollgaard Jensen, the company set out to improve quality of life for patients requiring ostomy care, and has since expanded into multiple clinical areas. Coloplast is headquartered in Humlebæk, Denmark, and combines in‐house research and development with strategic partnerships to drive innovation in its core markets.

The company’s product portfolio is organized around four primary areas: ostomy care, continence care, wound and skin care, and interventional urology. In ostomy care, Coloplast offers pouches, barrier rings and accessory products designed for secure, long‐wearing solutions. Its continence care range includes catheters, drainage bags and skin protection items for individuals managing urinary or fecal incontinence. In wound and skin care, the firm provides advanced dressings, compression garments and negative pressure therapy systems, while its interventional urology division focuses on minimally invasive tools for the diagnosis and treatment of conditions affecting the urinary tract.

Coloplast operates through a network of subsidiaries in more than 40 countries and distributes products via third‐party partners in additional markets across Europe, North America, Asia‐Pacific, Latin America, the Middle East and Africa. The company’s global footprint is supported by local sales, marketing and clinical teams that work closely with healthcare professionals and patient organizations to tailor solutions to regional needs.

Throughout its history, Coloplast has maintained a commitment to user‐driven innovation, drawing on direct feedback from patients and clinicians. While the company’s leadership has evolved over time, its enduring focus remains on delivering products that address sensitive healthcare needs, improve patient comfort and uphold stringent quality standards.

AI Generated. May Contain Errors.

Receive CLPBF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Coloplast A/S and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

CLPBF Stock News Headlines

Coloplast Might Have Found Its Bottom
Trump's New Dollar
Porter Stansberry says President Trump has signed an executive order initiating what he calls a full U.S. dollar reset - and most Americans don't know it's happening. The last time America underwent a monetary shift like this, under Nixon in the 1970s, it minted an average of 1,300 new millionaires a day for over half a century. Stansberry has released a new documentary naming the assets he believes are positioned to surge as a result.tc pixel
See More Headlines

CLPBF Stock Analysis - Frequently Asked Questions

Coloplast A/S's stock was trading at $83.70 on January 1st, 2026. Since then, CLPBF shares have decreased by 22.3% and is now trading at $65.02.

Shares of CLPBF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Today
8/15/2026
Next Earnings (Estimated)
8/18/2026

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Industry
Healthcare Equipment & Supplies
Sub-Industry
N/A
Current Symbol
OTCMKTS:CLPBF
CIK
1294325
Fax
N/A
Employees
15,930
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
5.69
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
N/A
Free Float
N/A
Market Cap
N/A
Optionable
Not Optionable
Beta
N/A
 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.

Get This Free Report

This page (OTCMKTS:CLPBF) was last updated on 8/15/2026 by MarketBeat.com Staff.
From Our Partners